Search results for “Immunooncology” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 370 patents, we discovered top 73 key players by total patent application. Novartis AG, Intellia Therapeutics, Inc., CRISPR Therapeutics AG are dominant in this area. They take 32.70% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 47
Massachusetts, United States
Patent: 42
Massachusetts, United States
Patent: 32
STARTUP
California, United States
Patent: 26
New York, United States
Patent: 21
South Korea
Patent: 16
STARTUP
United Kingdom
Patent: 15
Russia
Patent: 15
Basel-Stadt, Switzerland
Patent: 13
California, United States
Patent: 12
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 68 patents, we discovered top 13 start-ups by total patent application. Synthorx, Inc., Grey Wolf Therapeutics Ltd., Pathios Therapeutics Ltd. are active in this area.
STARTUP
California, United States
Patent: 26
STARTUP
United Kingdom
Patent: 15
STARTUP
United Kingdom
Patent: 10
STARTUP
Massachusetts, United States
Patent: 6
California, United States
Patent: 2
STARTUP
California, United States
Patent: 2
STARTUP
North Carolina, United States
Patent: 1
STARTUP
British Columbia, Canada
Patent: 1
STARTUP
South Korea
Patent: 1
STARTUP
Spain
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 296 patents applied in the last 5 years. We discover 73 most active companies in this area. The fast-growing CRISPR Therapeutics AG, Synthorx, Inc., Novartis AG take 27.03% of patent filing during this period.
Massachusetts, United States
Patent: 32
STARTUP
California, United States
Patent: 26
Basel-Stadt, Switzerland
Patent: 22
Massachusetts, United States
Patent: 19
South Korea
Patent: 16
New York, United States
Patent: 16
STARTUP
United Kingdom
Patent: 15
Basel-Stadt, Switzerland
Patent: 13
California, United States
Patent: 12
STARTUP
United Kingdom
Patent: 10
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 296 patents in last 5 years, we discover 66 new entrants. CRISPR Therapeutics AG, Synthorx, Inc., Ildong Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Massachusetts, United States
Patent: 32
STARTUP
California, United States
Patent: 26
South Korea
Patent: 16
STARTUP
United Kingdom
Patent: 15
Basel-Stadt, Switzerland
Patent: 13
California, United States
Patent: 12
STARTUP
United Kingdom
Patent: 10
STARTUP
Massachusetts, United States
Patent: 6
California, United States
Patent: 6
New South Wales, Australia
Patent: 6
Research Institutions
Order by:
Innovation Intensity
With the analysis among 18 patents, we discovered top 8 universities and scientific research institutions by total patent application. North Eastern University, Ghent University, Vlaams Instituut voor Biotechnologie - Flanders Institute are dominant in this area. They take 83.33% of the total patent filing.
Liaoning Sheng, China
Patent: 5
Oost-Vlaanderen, Belgium
Patent: 3
Belgium
Patent: 3
North Carolina, United States
Patent: 1
United States
Patent: 1
California, United States
Patent: 1
Colorado, United States
Patent: 1
South Korea
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: